Ligand validation:9HY2

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9HY2_IMD_A_303	50%	70%	0.158	0.909	0.16	0.84	-	-	0	0	100%	1
9HY1_IMD_A_304	34%	72%	0.184	0.872	0.15	0.79	-	-	0	0	100%	1
9HY3_IMD_A_304	15%	70%	0.232	0.802	0.33	0.68	-	-	0	0	100%	1
9HY5_IMD_A_304	11%	59%	0.279	0.808	0.7	0.72	-	-	0	0	100%	0.7
4RS3_IMD_A_413	100%	58%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	87%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
9FP4_IMD_A_402	100%	70%	0.036	0.993	0.23	0.76	-	-	0	0	100%	1
5OKB_IMD_B_502	99%	71%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	99%	49%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.